How does ER/PR and Her2/Neu status affect the MR characteristics of invasive ductal carcinoma?

被引：0
|
作者：
Jansen S A [1 ]
Shimauchi A [1 ]
Karczmar G S [1 ]
Newstead G [1 ]
机构：
[1] Univ Chicago, Chicago, IL USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [31] ER/PR and Her2/Neu Correlation between Immunohistochemisty and Gene Expression Profiling in Women with Invasive Breast Cancer
    Dydo, M.
    Shutter, J.
    LABORATORY INVESTIGATION, 2010, 90 : 44A - 44A
  • [32] Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results
    van Es, Suzanne C.
    van der Vegt, Bert
    Bensch, Frederike
    Gerritse, Sophie
    van Heiden, Erik J.
    Boon, Eline
    Angus, Lindsay
    Overbosch, Jelle
    van Oordt, Catharina W. Menke-van der Houven
    Verheul, Henk M.
    van Herpen, Carla M. L.
    Jager, Agnes
    Oosting, Sjoukje F.
    de Vries, Elisabeth G. E.
    Schroder, Carolina P.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (10) : 1355 - 1360
  • [33] Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma
    Xu, Aqiao
    Chu, Xiufeng
    Zhang, Shengjian
    Zheng, Jing
    Shi, Dabao
    Lv, Shasha
    Li, Feng
    Weng, Xiaobo
    BMC CANCER, 2022, 22 (01)
  • [34] Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma
    Aqiao Xu
    Xiufeng Chu
    Shengjian Zhang
    Jing Zheng
    Dabao Shi
    Shasha Lv
    Feng Li
    Xiaobo Weng
    BMC Cancer, 22
  • [35] Correlation of CCND1 Amplification with Hormone Receptor (ER, PR) Expression and ERBB2 (Her2/neu) Gene Amplification in Invasive Ductal Carcinoma of the Breast: A Study of 102 Cases
    Chang, M. C.
    Ocal, I. T.
    Taneja, K.
    Dillon, D. A.
    MODERN PATHOLOGY, 2010, 23 : 39A - 39A
  • [36] Correlation of CCND1 Amplification with Hormone Receptor (ER, PR) Expression and ERBB2 (Her2/neu) Gene Amplification in Invasive Ductal Carcinoma of the Breast: A Study of 102 Cases
    Chang, M. C.
    Ocal, I. T.
    Taneja, K.
    Dillon, D. A.
    LABORATORY INVESTIGATION, 2010, 90 : 39A - 39A
  • [37] Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in inv'asive mammary ductal carcinoma associated with ductal carcinoma in situ (DCIS) versus invasive breast cancer alone
    Mylonas, I
    Makovitzky, J
    Jeschke, U
    Briese, V
    Friese, K
    Gerber, B
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1719 - 1723
  • [38] Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma
    Peng, Jian-Heng
    Zhang, Xiang
    Song, Jun-Long
    Ran, Liang
    Luo, Rong
    Li, Hong-Yuan
    Wang, Yong-Hong
    MEDICINE, 2019, 98 (02)
  • [39] The Concordance of Estrogen and Progesterone Receptor Status (ER-PR), and Her-2/Neu Expression in DCIS Coexistent with Micro-Invasive and Invasive Carcinoma
    Ahmed, Q.
    Ali-Fehmi, R.
    Sakr, W.
    Nahleh, Z.
    Hussein, Y.
    Ibrahim, M.
    Albashiti, B.
    Hayek, K.
    Khalifeh, I.
    Bandyopadhyay, S.
    MODERN PATHOLOGY, 2010, 23 : 33A - 33A
  • [40] The Concordance of Estrogen and Progesterone Receptor Status (ER-PR), and Her-2/Neu Expression in DCIS Coexistent with Micro-Invasive and Invasive Carcinoma
    Ahmed, Q.
    Ali-Fehmi, R.
    Sakr, W.
    Nahleh, Z.
    Hussein, Y.
    Ibrahim, M.
    Albashiti, B.
    Hayek, K.
    Khalifeh, I.
    Bandyopadhyay, S.
    LABORATORY INVESTIGATION, 2010, 90 : 33A - 33A
12345